Practice question

Answer the question and get instant feedback.

MediumGLP‑1 RAKDIGO Guideline (2024): CKD; ADA Standards of Care (2025)endocrinology

A 68-year-old with T2D and CKD presents with hyperglycaemia (no DKA). Which antihyperglycaemic should be avoided with eGFR 25 mL/min/1.73 m² due to limited efficacy?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.